aap Implantate Posts 3Q16 Revenue
aap Implantate reported 3Q16 trauma product revenue of €2.9MM (~US $3.1MM), -14.8% vs. 3Q15. Growth is as reported.
aap completed the sale of its orthobioogics division in mid-2Q16; all remaining operations address trauma products.
In North America, sales to local distributors and global partners grew to ~$0.75MM, up from ~$0.11MM in 3Q15.
Noted significant increase of procedures using aap trauma products in North America
After the quarter's close, aap launched a Polyaxial LOQTEQ® VA Ankle System and a Periprosthetic LOQTEQ System. Additional launches are anticipated for a variety of polyaxial LOQTEQ systems for a range of anatomic applications.
Sources: aap Implantate AG; ORTHOWORLD Inc.